2021
DOI: 10.3389/fbioe.2021.723490
|View full text |Cite
|
Sign up to set email alerts
|

Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy

Abstract: Immunotherapy has emerged as a promising strategy for cancer treatment, in which durable immune responses were generated in patients with malignant tumors. In the past decade, biomaterials have played vital roles as smart drug delivery systems for cancer immunotherapy to achieve both enhanced therapeutic benefits and reduced side effects. Hydrogels as one of the most biocompatible and versatile biomaterials have been widely applied in localized drug delivery systems due to their unique properties, such as load… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
21
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(22 citation statements)
references
References 62 publications
0
21
0
Order By: Relevance
“…12,13 To address this issue, various methods have been developed to reduce the amount of drug absorbed into the blood vessels and enhance the continuous release of the drug using different drug delivery systems, such as hydrogels, microneedles, and implant. [14][15][16] However, the hydrogel may not be injected at the target location inside the tumor because of the high internal pressure and may be easily transferred to non-target sites. [17][18][19] Additionally, the drug may not spread throughout the tumor but only within the vicinity of the hydrogel.…”
Section: Introductionmentioning
confidence: 99%
“…12,13 To address this issue, various methods have been developed to reduce the amount of drug absorbed into the blood vessels and enhance the continuous release of the drug using different drug delivery systems, such as hydrogels, microneedles, and implant. [14][15][16] However, the hydrogel may not be injected at the target location inside the tumor because of the high internal pressure and may be easily transferred to non-target sites. [17][18][19] Additionally, the drug may not spread throughout the tumor but only within the vicinity of the hydrogel.…”
Section: Introductionmentioning
confidence: 99%
“…The 3D macroscale platforms have been widely investigated as drug delivery systems [ 102 , 103 ]. Different kinds of immunomodulatory agents could be simply incorporated into them via gentle procedures.…”
Section: Modern Immunotherapeutic Strategies Based On 3d Macroscale B...mentioning
confidence: 99%
“…When injected into the tumor site, the hydrogel undergoes swelling and degradation due to the low pH of the tumor, releasing the loaded therapeutic agent, thereby stimulating dendritic cells or pre‐stimulated tumor‐specific T cells to attract immune cells to the tumor site. [ 85,90 ]…”
Section: Light‐triggered Nanocomposite Hydrogels For Diverse Biomedic...mentioning
confidence: 99%